Legislature(2023 - 2024)DAVIS 106
02/07/2023 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB17 | |
| HB58 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 17 | TELECONFERENCED | |
| *+ | HB 58 | TELECONFERENCED | |
HB 17-CONTRACEPTIVES COVERAGE:INSURE;MED ASSIST
3:03:40 PM
CHAIR PRAX announced that the first order of business would be
HOUSE BILL NO. 17, "An Act relating to insurance coverage for
contraceptives and related services; relating to medical
assistance coverage for contraceptives and related services; and
providing for an effective date."
3:04:32 PM
REPRESENTATIVE ASHLEY CARRICK, Alaska State Legislator, as prime
sponsor, presented HB 17. She stated that since the mid-'90s,
28 states have required health insurance plans regulated by the
state to provide coverage of prescription drugs and devices,
including contraceptives. Under a provision of the Affordable
Care Act of 2010 (ACA), these state policies were expanded in
several ways. She said ACA's contraceptive coverage guarantee
extends from Section 13 of the Public Health Service Act, which
requires non-grandfathered health insurance coverage and
employer-sponsored group health plans to cover preventive
services without cost-sharing. She said Section 27.13 required
coverage of women's preventive services, as defined by the
Health Resources and Service Administration (HRSA). She said
HRSA asked the then Institute of Medicine to recommend that
women's preventative services be covered, and based on this
recommendation, HRSA defined women's preventative services to
include all contraceptives approved by the U.S. Food and Drug
Administration (FDA) and patient education and counseling for
"women of reproductive capacity," as prescribed by a health care
provider, collectively referred to as "contraceptive services."
The final preventative services rules required insurers and
group health plans to cover all such contraceptive services.
REPRESENTATIVE CARRICK said more recently some states have
amended and expanded their own requirements to match the federal
guarantee. She offered examples. She said HB 17 would put into
statute language consistent with the federal standards. It
would also mandate dispensing coverage of contraceptives up to
12 months at a time. She noted that Alaskans often face
numerous challenges when trying to access contraceptives,
especially in rural areas where it is not feasible to travel
multiple times to a pharmacy in a larger community.
Additionally, some women work in high demand jobs that take them
away from access to pharmacies, such as working on the North
Slope, on fishing vessels, or in the mining industry. She
argued that a one-year supply of contraceptives could assist
many women to balance their health with their professional work.
She cited research in the Journal of Obstetrics and Gynecology
[hard copy included in the committee packet] as showing that
women who are dispensed a 12-month supply of contraceptives have
a 30 percent drop in unplanned pregnancy and a 46 percent drop
in "the likelihood of abortion" compared to women dispensed a 1-
to 3-month supply. Representative Carrick stated that HB 17
would also save money for the state. Based on prior, similar
legislation, the former Department of Health and Social Services
estimated a $1.35 million savings annually due to a reduction in
unplanned pregnancies. She pointed out that HB 17 has zero
fiscal impact. She expressed her knowledge that improved access
to contraceptives means improved health for women and families.
She said providers are still able to make decisions in
consultation with their patients; the proposed legislation would
take "insurance coverage away as a barrier to access."
3:08:46 PM
REPRESENTATIVE CARRICK stated that HB 17 would offer the
additional benefit of protecting victims of domestic violence.
She noted that in the past few years there has been an increased
awareness of domestic violence and sexual assault. She talked
about contraceptive coercion as being a form of domestic or
interpersonal violence by which abusers "dictate when and how
contraceptives can or cannot be accessed as a means of being in
power or control." She stated, "Contraceptive services have
long been recognized by both government and a wide range of
private sector experts as a vital and effective component of
preventative and public health care." She talked about the
benefits of contraceptive use in preventing unintended pregnancy
and improving "birth spacing." She noted that there had been
letters of support for previous versions of this legislation
from organizations such as the Alaska Network of Domestic
Violence and Sexual Assault (ANDVSA), the Alaska Public Health
Association, and the League of Women Voters; and there are
updated letters and resolutions from entities in support of HB
17. Representative Carrick concluded by stating that HB 17
makes sense for Alaska women and families. She introduced her
staff to provide the sectional analysis.
3:10:41 PM
CHERIE BOWMAN, Staff, Representative Ashley Carrick, Alaska
State Legislature, on behalf of Representative Carrick, prime
sponsor of HB 17, provided the sectional analysis [included in
the committee packet], which read as follows [original
punctuation provided]:
Section 1
AS 21.42.427. Coverage for contraceptives.
Amends AS 21.42 by adding a new section which (1)
requires a health care insurer to provide coverage for
prescription contraceptives and medical services
necessary for those products or devices (including
over-the-counter emergency contraception that was
obtained without a prescription); (2) requires
reimbursement to a health care provider or dispensing
entity for dispensing prescription contraceptives
intended to last for a 12-month period for subsequent
dispensing; (3) prevents an insurer from offsetting
the costs of compliance; (4) prevents an insurer from
restricting or delaying coverage for contraceptives;
(5) if the provider recommends a particular service or
FDA-approved item based on a determination of medical
necessity, the plan or issuer must cover that service
or item without cost sharing; and (6) exempts
religious employers if certain criteria are met.
Section 2
AS 29.10.200. Limitation of home rule powers.
Amends AS 29.10.200 by adding a provision applying to
home rule municipalities.
Section 3
AS 29.20.420. Health insurance policies.
Amends AS 29.20 by adding a new section clarifying
that municipal health care insurance plans that are
self-insured are subject to the requirements of sec.
1.
Section 4
AS 39.30.090. Procurement of group insurance.
Clarifies that a group health insurance policy
covering employees of a participating governmental
unit is subject to the requirements of sec. 1.
Section 5
AS 39.30.091. Authorization for self-insurance and
excess loss insurance.
Clarifies that a self-insured group medical plan
covering active state employees provided under this
section is subject to the requirements of sec. 1.
Section 6
AS 47.07.065. Payment for prescribed drugs.
Requires the Department of Health and Social Services
to pay for prescription contraceptives intended to
last for a 12-month period for subsequent dispensing
for eligible recipients of medical assistance, if
prescribed to and requested by the recipient, as well
as medical services necessary for Distributed by the
Office of Representative Ashley Carrick 1.25.2023 2
those products or devices. The Department of Health
and Social Services must also provide coverage for
over-the-counter emergency contraception that was
obtained without a prescription.
Section 7
Uncodified law applicability
Requires the Department of Health to immediately amend
and submit for federal approval a state plan for
medical assistance coverage consistent with sec. 6 of
this Act.
Section 8
Uncodified law applicability
Makes sec. 6 of the Act conditional on the approval
required under sec. 7 of the Act.
Section 9
Uncodified law applicability
If, under sec. 8 of this Act, sec. 6 of this Act takes
effect, it takes effect on the day after the date the
revisor of statutes receives notice from the
commissioner of health and social services under sec.
8 of this Act.
3:15:10 PM
REPRESENTATIVE MINA expressed appreciation to the bill sponsor
and asked whether "the month-span for different types of
contraceptives" is found in statute or regulations.
3:15:59 PM
REPRESENTATIVE CARRICK offered her understanding that it is
typically within a one- to three-month span depending on patient
needs, in consultation with the provider.
3:16:31 PM
REPRESENTATIVE SADDLER, seeking a baseline, asked about current
limits to the duration of a prescription for any medication.
REPRESENTATIVE CARRICK answered she is not sure and suggested
Ms. Wing-Heier from the Division of Insurance could provide an
answer.
3:17:46 PM
REPRESENTATIVE RUFFRIDGE directed attention to language in HB
17, [Section 1, paragraph (2)], on page 2, lines 5-9, which read
as follows:
(2) reimburse a health care provider or dispensing
entity for dispensing prescription contraceptives
intended to last for a 12-month period for subsequent
dispensings of the same prescription contraceptive to
the insured regardless of whether the insured was
enrolled in the health care insurance plan at the time
of the first dispensing.
REPRESENTATIVE RUFFRIDGE asked for more information regarding
the part about enrollment.
REPRESENTATIVE CARRICK offered her understanding that that
potentially may allow for some type of reimbursement, but
deferred again to Ms. Wing-Heier.
REPRESENTATIVE RUFFRIDGE then directed attention to the repeated
use of the term "emergency contraception" in HB 17, first seen
on page 1, line 11, and he offered his understanding that
emergency contraception is available over the counter (OTC). He
asked whether the intent of the bill language was that a person
would go get emergency contraception from wherever it is sold
and expect to obtain it at no charge upfront.
REPRESENTATIVE CARRICK answered that she thinks the language
means that someone who has [insurance] coverage for "Plan B"
[emergency contraception] and purchases it could submit for
reimbursement. This would allow someone to get Plan B without
having to first make an appointment with a medical provider to
get a prescription, which can be a burden. She said she thinks
it does not mean the person could get it at no cost upfront.
REPRESENTATIVE RUFFRIDGE highlighted language on page 2,
beginning on line 26: "cost containment measure does not
unreasonably limit choice in access to coverage". He asked what
would be considered unreasonable.
REPRESENTATIVE CARRICK, in response, offered her understanding
that that is not defined in statute, but the reason for this
language is to ensure that people are incentivized "to go for
generics as much as possible." In response to a follow-up
question regarding restrictions in cost-containment measures
related to prescriptions, and whether that may refer to mail
order prescriptions, she related the key goal of HB 17 is to
provide access to contraceptives.
3:24:24 PM
REPRESENTATIVE SADDLER indicated concern that HB 17 may provide
"special consideration for this particular kind of
prescription." He also questioned whether there was such a
thing as reasonable limitations of choice in terms of
contraceptive prescriptions.
REPRESENTATIVE CARRICK emphasized that emergency contraceptives
are not the same thing as an abortifacient drug. She said she
would like to find out more about the issue of what is
reasonable. That said, she reiterated that the goal of HB 17 is
"to direct toward generics in order to help with the cost
containment." In response to a follow-up question, she
highlighted the medical difference between emergency
contraception and an abortifacient drug.
REPRESENTATIVE SADDLER asked about the cost of HB 17 to the
State of Alaska.
3:28:42 PM
LORI WING-HEIER, Director, Anchorage Office, Division of
Insurance Director, Department of Commerce, Community & Economic
Development, addressed the previously asked questions regarding
cost and what is reasonable. She confirmed that based on
previous iterations of this legislation, insurance companies had
determined the cost would be negligible. Contraceptives would
still be covered; the difference would be in the cost-sharing,
which is the person's deductible and co-pay, which she estimated
would be about $3. She said HB 17 is asking those be waived in
dispensing birth control. She said she could not think of an
example of a contraceptive pill on the market today where there
would be "an unreasonable expectation or an unreasonable limit
for [the generic version] to be dispensed in the state of
Alaska." The only exception she could think of, she said, would
be in a case where an individual worked on the North Slope, for
example, and had come to Fairbanks to pick up a prescription for
a contraceptive, and the pharmacy was currently out of the
generic brand. In this scenario, she opined, it would be
unreasonable to send the person back to the North Slope without
the prescription when a brand-name drug could be substituted.
3:31:20 PM
REPRESENTATIVE RUFFRIDGE reiterated his question about cost-
containment measures. He offered understanding about the
Medicaid system using cost-management techniques, and he asked
if "this bill would override those for Medicaid." He asked
whether HB 17 could result in a slight increase in cost to
Medicaid.
MS. WING-HEIER responded that the division is not involved with
Medicaid; therefore, she cannot speak to that issue.
3:32:44 PM
REPRESENTATIVE SUMNER asked if there is any "strong reason" this
should not be applied to all medications that do not have "an
abuse potential."
MS. WING-HEIER responded that a provider currently can prescribe
a 12-month dose of whatever medication a patient needs, but the
insurance plan may be the limiting factor by only paying for 3
months at a time. In response to a follow-up question, she
confirmed that is what is trying to be addressed under HB 17.
3:33:48 PM
REPRESENTATIVE CARRICK added that HB 17 could be more
comprehensive and include other types of medication, but the
reason she is carrying the proposed legislation is because many
women have specifically asked for 12-month contraceptive
prescriptions to be allowed.
3:34:53 PM
REPRESENTATIVE SADDLER asked what the justification is to limit
any other drug to a three-month prescription and whether there
is a therapeutic benefit to doing so.
3:35:26 PM
MS. WING-HEIER noted that often a physician gives a patient a
drug on a trial basis and asked the patient to come back for
blood work in three months to determine the efficacy of the
drug. In response to a follow-up question, she said this may be
beyond her expertise, but she supposed birth control is a drug
that is not looked at as heavily as looking at lab work; rather
it is a matter of determining effectiveness in preventing
[conception].
3:36:34 PM
CHAIR PRAX announced that HB 17 was held over.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB 17 Support Document - Public Costs From Unintended Pregnancies February 2015.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Unintended Pregnancies Study March 2011.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - UCSF Study Newspaper Article 2.22.2011.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - HRSA Women's Preventive Services Guidelines.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Insurance Coverage of Contraceptives 4.01.2021.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Guttmacher Alaska Statistics 2016.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 v. A Sponsor Statement.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB17 Version A.PDF |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 58 Sponsor Statement.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| HB 58 Summary Version A.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| HB 58 Version A.PDF |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| HB 58 Sectional Analysis Version A.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| HB 17 v. A Sectional Analysis.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 58 Presentation.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| HB 17 Support Letter.docx |
HHSS 2/7/2023 3:00:00 PM |
HB 17 |
| Support letter for HB 58 Redacted.docx |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |
| Opposition Letter for HB 17 Redacted.docx |
HHSS 2/7/2023 3:00:00 PM |
HB 17 |
| HB 58 Support Letter 2 Redacted.docx |
HHSS 2/7/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 58 |